Treace Medical Concepts (TMCI) Change in Acquisitions & Divestments (2022 - 2026)

Treace Medical Concepts has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $11.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 32.39% year-over-year to $11.3 million; the trailing twelve-month figure through Mar 2026 stood at $61.9 million (down 37.39% YoY), and the FY2025 full-year result was $67.3 million, down 43.2% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $11.3 million, down from $17.7 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $37.0 million in Q4 2023, with the low at $1.7 million in Q4 2022.
• Historically, Change in Acquisitions & Divestments has averaged $22.8 million across 5 years, with a median of $22.4 million in 2023.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments soared 2042.57% — and 2025, when it tumbled 54.01%.
• Treace Medical Concepts' Change in Acquisitions & Divestments stood at $1.7 million in 2022, then soared by 2042.57% to $37.0 million in 2023, then slumped by 32.02% to $25.2 million in 2024, then declined by 29.53% to $17.7 million in 2025, then sank by 36.23% to $11.3 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $11.3 million (Q1 2026), $17.7 million (Q4 2025), and $16.2 million (Q3 2025), per Business Quant data.